Financial News
Latest News about LLY
Recent news which mentions LLY
Jim Cramer Likes This Stock Over Cassava Sciences And Biogen
November 17, 2021
From Benzinga
Could Eli Lilly Leapfrog Biogen in This Market?
November 17, 2021
From Motley Fool
3 Pharma Stocks That Could Make You Richer in November (and Beyond)
November 12, 2021
From Motley Fool
Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters
November 10, 2021
From Benzinga
A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
November 05, 2021
From Benzinga
A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
November 05, 2021
From Benzinga
Why AbCellera Biologics Stock Sank 21.6% in October
November 04, 2021
From Motley Fool
What Investors Should Like About Eli Lilly's Q3 Update
November 04, 2021
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
From Benzinga
Down 76%: Is Cortexyme Stock a Bargain?
October 28, 2021
From Motley Fool
From Benzinga
Cortexyme's Alzheimer's Drug Fails -- 2 Lessons for Investors
October 28, 2021
From Motley Fool
Eli Lilly and Company (LLY) Q3 2021 Earnings Call Transcript
October 26, 2021
Tickers
LLY
From Motley Fool
From Benzinga
Eli Lilly Q3 Earnings Beat Estimates, Boosts FY21 Guidance On Higher COVID-19 Therapy Sales
October 26, 2021
Tickers
LLY
From Benzinga
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
October 26, 2021
From Benzinga
A Peek Into The Markets: US Stock Futures Rise Ahead Of Big Earnings
October 26, 2021
From Benzinga
7 Stocks To Watch For October 26, 2021
October 26, 2021
From Benzinga
Earnings Scheduled For October 26, 2021
October 26, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
The Federal Reserve’s next interest rate-hike cycle is coming but may not look like what officials have been projecting
October 23, 2021
From MarketWatch
From Motley Fool
A-List Executive Team, Big-Name Backers Fail to Lift Abbisko IPO
October 22, 2021
From Benzinga
Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?
October 22, 2021
From Motley Fool
If I Could Only Own 1 Healthcare Stock, This Is What It Would Be
October 21, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.